Expression of microRNAs of C19MC in different histological types of testicular germ cell tumour

I Flor, M Spiekermann, T Loening… - Cancer genomics & …, 2016 - cgp.iiarjournals.org
Background: Testicular germ cell tumours (TGCTs) are the most common tumours in men
aged from 20 to 40 years, with a steadily increasing incidence. This study aimed to …

Differential expression of miRNAs in the seminal plasma and serum of testicular cancer patients

M Pelloni, G Coltrinari, D Paoli, F Pallotti, F Lombardo… - Endocrine, 2017 - Springer
Various microRNAs from the miR-371-3 and miR-302a–d clusters have recently been
proposed as markers for testicular germ cell tumours. Upregulation of these miRNAs has …

[HTML][HTML] MicroRNA miR-371a-3p-a novel serum biomarker of testicular germ cell tumors: evidence for specificity from measurements in testicular vein blood and in …

KP Dieckmann, M Spiekermann, T Balks… - Urologia …, 2016 - karger.com
Background: microRNAs (miRs)-371-3 are suggested to be novel biomarkers of germ cell
tumors (GCTs), but their specificity is unresolved. We aimed at clarifying the origin of miR …

MicroRNAs in differentiation of embryoid bodies and the teratoma subtype of testicular cancer

MP Myklebust, AM Søviknes… - Cancer genomics & …, 2022 - cgp.iiarjournals.org
Background: Testicular germ cell tumours (TGCTs) are the most frequent tumour type among
young, adult men. TGCTs can be efficiently treated, but metastases of the teratoma subtype …

[HTML][HTML] Serum levels of microRNA371a-3p: a highly sensitive tool for diagnosing and staging testicular germ cell tumours: a clinical case series

P Anheuser, A Radtke, C Wülfing, J Kranz… - Urologia …, 2017 - karger.com
Abstract Introduction: MicroRNA (miR) 371a-3p was suggested to be a sensitive and specific
new serum biomarker of germ cell tumours (GCTs); however, its clinical usefulness remains …

[HTML][HTML] MicroRNAs miR-371-3 in serum as diagnostic tools in the management of testicular germ cell tumours

KP Dieckmann, M Spiekermann, T Balks, I Flor… - British journal of …, 2012 - nature.com
Background: miRNAs are small noncoding RNA molecules that can be released into body
fluids. Germ cell tumours (GCTs) overexpress miRNAs of the miR-371-3 cluster. Thus, serum …

[HTML][HTML] Graded expression of microRNA-371a-3p in tumor tissues, contralateral testes, and in serum of patients with testicular germ cell tumor

G Belge, F Hennig, C Dumlupinar, F Grobelny… - Oncotarget, 2020 - ncbi.nlm.nih.gov
Background: Serum levels of microRNA-371a-3p represent a specific tumor marker of
testicular germ cell tumors (GCTs) but the origin of circulating miR-371a-3p is not finally …

Serum level of microRNA-375-3p is not a reliable biomarker of teratoma

G Belge, F Grobelny, C Matthies, A Radtke… - in vivo, 2020 - iv.iiarjournals.org
Background/Aim: Clinical management of testicular germ cell tumours (GCT) is based upon
the measurement of serum tumour markers. Recent studies have shown that the microRNA …

[HTML][HTML] Non-coding microRNAs as novel potential tumor markers in testicular cancer

M Regouc, G Belge, A Lorch, KP Dieckmann, M Pichler - Cancers, 2020 - mdpi.com
Testicular cancer is an important disease with increasing incidence and a high burden of
morbidity and mortality in young men worldwide. Histological examination of the testicular …

Is relative quantification dispensable for the measurement of microRNAs as serum biomarkers in germ cell tumors?

M Spiekermann, KP Dieckmann, T Balks… - Anticancer …, 2015 - ar.iiarjournals.org
Background: Classical biomarkers α-fetoprotein, β-human chorionic gonadotropin and
lactate dehydrogenase (AFP, bHCG and LDH) are elevated in only 60% of all testicular …